Phenprocoumon Versus Dabigatran in Subjects With Atrial Fibrillation and Left Atrial Thrombus - a Prospective, Randomized, Controlled, Open-label One Year Follow-up Pilot Study
Phase of Trial: Phase IV
Latest Information Update: 05 Dec 2017
At a glance
- Drugs Dabigatran etexilate (Primary) ; Phenprocoumon
- Indications Atrial fibrillation; Thrombosis
- Focus Therapeutic Use
- 22 Oct 2017 Status changed from recruiting to discontinued.
- 12 Nov 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 02 Nov 2015 New trial record